0001401914-24-000002.txt : 20240129 0001401914-24-000002.hdr.sgml : 20240129 20240129161834 ACCESSION NUMBER: 0001401914-24-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240126 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haring-Layton MarDee CENTRAL INDEX KEY: 0001535596 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 24573903 MAIL ADDRESS: STREET 1: 16870 WEST BERNARDO DRIVE STREET 2: SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-926-7655 MAIL ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 3 1 wk-form3_1706563099.xml FORM 3 X0206 3 2024-01-26 0 0001401914 Dare Bioscience, Inc. DARE 0001535596 Haring-Layton MarDee C/O DARE BIOSCIENCE, INC. 3655 NOBEL DRIVE, SUITE 260 SAN DIEGO CA 92122 0 1 0 0 Chief Accounting Officer Employee Stock Option (right to buy) 2.37 2028-01-16 Common stock 3500 D Employee Stock Option (right to buy) 1.01 2028-09-07 Common stock 30000 D Employee Stock Option (right to buy) 0.759 2029-01-29 Common stock 35000 D Employee Stock Option (right to buy) 1.03 2030-03-06 Common stock 25000 D Employee Stock Option (right to buy) 2.59 2031-01-26 Common stock 52000 D Employee Stock Option (right to buy) 1.59 2032-01-26 Common stock 42000 D Employee Stock Option (right to buy) 1.16 2033-01-24 Common stock 80000 D This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer. /s/ MarDee Haring-Layton 2024-01-29